Skip to main content
. 2001 Mar 6;98(6):3358–3363. doi: 10.1073/pnas.061607398

Figure 1.

Figure 1

Increasing Tx biosynthesis during atherogenesis in LDLR-KO mice. Excretion of the major urinary metabolite of Tx, 2,3-dinor TxB2, in LDLR-KO mice on a Western-type diet receiving placebo (open bars), indomethacin (hatched bars), or nimesulide (closed bars) at 8 weeks of age and after 18 weeks of treatment (26 weeks of age). (*, P < 0.001.)